Changes of Plasma Lipids and Lipoprotein Levels during Danazol Treatment for Endometriosis

Karl-Werner Schweppe, K W Schweppe, G Assmann, G. Aßmann
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme · 1984 · vol. 16(11) , pp. 593–597 · doi:10.1055/s-2007-1014859 · PMID:6510890 · W2077880187
article OA: closed CC0 ⤵ 8 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-09 ⓘ

Danazol treatment for endometriosis caused a significant decrease in HDL, a potential increase in LDL, a doubling of the atherogenic ratio, and decreased estradiol and progesterone levels.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Previous data of lipid and lipoprotein level changes with the application of danazol, an isoxazol derivative of 17-alpha-ethinyl testosterone, have been conflicting. We measured cholesterol, triglycerides, low density lipoproteins and high density lipoproteins, estradiol and progesterone in 62 patients treated for endometriosis with danazol 600 mg daily. The fasting blood samples were taken before, every month during danazol medication, and 4, 12 and 24 weeks after cessation of therapy. Inconsistent changes in total cholesterol and triglyceride levels were observed. The data showed a constant, though not significant increase of the mean LDL levels. Plasma HDL decreased approximately 45% during the first two months of danazol influence and remained constantly low for the rest of the treatment. The atherogenic ratio (LDL:HDL) was doubled by-danazol. Five patients developed a reversible type IIa hyperlipoproteinemia. The plasma levels of estradiol decreased, but showed normal midfollicular values during the treatment period. In contrast, the plasma levels of progesterone fell significantly and were sometimes undetectable. These findings demonstrate an atherogenic potential of danazol, especially when long term treatment is taken into consideration.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Danazol Endometriosis Lipids Lipoproteins Pregnadienes Adult Cholesterol Cholesterol Danazol Endometriosis Endometriosis Estradiol Estradiol Female Humans Lipids Lipoproteins Lipoproteins, HDL Lipoproteins, HDL Lipoproteins, LDL

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

Cited by (8)

Source provenance

europepmc
last seen: 2026-06-21T06:12:49.409960+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:09:50.790931+00:00
License: CC0 · commercial use OK